Halozyme Therapeutics $HALO (+2.15%) mit starken Quartalszahlen und nem bombenstarken Ausblick.
Hab gleich mal paar Aktien nachgekauft.
Zusammenfassung von Yahoo Finance:
Announcing New $250M Share Repurchase
Total Revenue Increased 35% YOY to $265 million
Royalty Revenue Increased 39% YOY to $168 million
Net Income Increased 54% YOY to $118 million;
Adjusted EBITDA Increased 40% YOY to $162 million;
GAAP Diluted EPS Increased 55% YOY to $0.93; non-GAAP Diluted EPS Increased 41% YOY to $1.111
Raising 2025 Financial Guidance Ranges for Total Revenue to $1,200 - $1,280 million, Representing YOY Growth of 18% - 26%, Adjusted EBITDA to $790 - $840 million, Representing YOY Growth of 25% - 33% and non-GAAP Diluted EPS to $5.30 - $5.70, Representing YOY Growth of 25% - 35%1